New-York-based Hey Jane provides abortion care services including virtual consultations and US Food and Drug Administration (FDA) approved abortion treatments.
Hey Jane serves adult women who are up to 10 weeks pregnant and charges them USD 249 for the abortion treatment which includes prescription medication and shipping. The company also provides follow-up virtual visits and the option to chat with its physician team during the procedure. The treatment consists of two pills: mifepristone, which terminates the pregnancy, and misoprostol, which empties the uterus. As of September 2021, the company experienced a 98% effectiveness rate.
Funding and financials
In October 2022, the company r aised USD 6.1 million in a venture funding round which had participation from several female-led venture capital firms as well as other investors. The company set aside the raised funds to hire additional employees, grow its operations to other states, secure additional partnerships with enterprise clients and health plans, and expand its services offered to treat other conditions such as postpartum depression and anxiety. The company also announced its plans to increase its coverage to all 50 states by the end of 2023.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.